Abstract:Objective To investigate the effects of magnesium sulfate on oxidative stress injury and hypoxia-inducible factor 1α (HIF-1α) expression level in placental tissues of preeclampsia rats. Methods Thirty SD rats were randomly divided into the blank control group, preeclampsia (PE) group, and magnesium sulfate group (n=10 each) . Except for the blank control group, endotoxin was used in the other groups to establish PE rat model. The magnesium sulfate group was given intraperitoneal injection of 80 mg/kg magnesium sulfate. The blank control group and PE group were injected with the same dose of normal saline. The cesarean section was performed at 21 d after pregnancy, and the placenta tissues were isolated. The level of HIF-1α in the placenta tissues was measured by real-time fluorescence quantitative polymerase chain reaction (RT-PCR) method. The levels of glutathione peroxidase (GPX) , malondialdehyde (MDA) and superoxide dismutase (SOD) in the placenta tissues were determined by ultraviolet colorimetry. The tissue homogenate method was used to determine the reactive oxygen species (ROS) level in the placenta tissues. Results (1) At 10 d after the pregnancy, there were no statistically significant differences in the blood pressure and 24 h urinary protein quantification between the groups (all P>0.05) . At 15 d and 21 d after the pregnancy, there were no significant change in the blood pressure and 24 h urinary protein quantification in the blank control group, whereas the above indexes increased in the PE group and magnesium sulfate group (all P<0.05) , and there were statistically significant differences compared with those at 10 d after pregnancy in the same group (all P<0.05) . The blood pressure and 24 h urine protein quantification in the PE group and magnesium sulfate group were higher than those in the blank control group during the same time period (all P<0.05) . The blood pressure and 24 h urine protein quantification in the magnesium sulfate group were lower than those in the PE group (all P<0.05) . (2) The placenta weight, and weight and length of newborn rats in the PE group were lower than those in the blank control group (all P<0.05) , whereas the indexes in the magnesium sulfate group were higher than those in the PE group (all P<0.05) . (3) The levels of GPX and SOD in placental tissues in the PE group and magnesium sulfate group were lower than those in the blank control group (all P<0.05) , whereas the levels of MDA, ROS and HIF-1α mRNA were higher than those in the blank control group (all P<0.05) . The levels of GPX and SOD in the magnesium sulfate group were higher than those in the PE group, whereas the levels of MDA, ROS and HIF-1α mRNA were lower than those in the PE group (all P<0.05) . Conclusion PE rats show significant oxidative stress injury, and the mRNA level of HIF-1α is significantly high in placenta tissues. The intervention with magnesium sulfate may reduce oxidative stress injury and down-regulate the mRNA expression level of HIF-1α. Key words: Pre-eclampsia; Magnesium sulfate; Oxidative stress; Placenta; Hypoxia-inducible factor 1α

Effect of the loading dose of magnesium sulfate on the Doppler velocimetry parameters in the uterine, umbilical and fetal middle cerebral arteries in severe preeclampsia

Effects of intrathecal magnesium sulfate in severe pre- eclampsia patients undergoing cesarean section

Magnesium Sulfate Decreases Cerebral Perfusion Pressure in Preeclampsia

Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks

Umbilical and middle cerebral arteries Doppler velocimetry in early and late onset pre-eclampsia

Effects of antenatal magnesium sulfate therapy on cerebral and systemic hemodynamics in preterm newborns

Umbilical artery pH may be a possible confounder for neonatal adverse outcomes in preterm infants exposed to antenatal magnesium

Mechanisms of the effect of magnesium salts in preeclampsia

Effects of vasoactive agents on isolated human umbilical arteries in preeclamptic women treated with magnesium sulfate: a preliminary report

Short-term effect of Magnesium sulfate Infusion on renal function in preeclamptic women

Effects Of Magnesium Sulfate On Heart Rate, Blood Pressure Variability And Baroreflex Sensitivity In Preeclamptic Rats Treated With L-Name

Assessment of transcranial Doppler indices after MgSO4 administration in severe preeclamptic women with neurologic symptoms

Magnesium sulfate in preeclampsia: Broad indications, not only in neurological symptoms

The Effect of Magnesium Sulfate on Cystatin C and Thrombomodulin in Patients with Preeclampsia

A Clinical Study after Preeclampsia Syndrome Therapy with Magnesium Sulfate and Nifudipine

Effects of Magnesium Sulfate on Oxidative Stress Injury and Hypoxia-Inducible Factor 1α Expression Level in Placental Tissues of Preeclampsia Rats

Effect of Magnesium Sulfate on Epidural Labor Analgesia with Ropivacaine in Patients with Preeclamp-Sia

Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia

Use of non-invasive cardiac monitoring to guide discontinuation of postpartum magnesium sulfate in individuals with preeclampsia with severe features

Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate

Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia